StockWatch
·

NATCO PHARMA LTD. Q3 FY26 Results

NATCOPHARMQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue647.3052.5%36.3%
Total Income705.4051.8%8.3%
Expenditure544.3035.9%11.7%
PBT161.1073.8%1.6%
Net Profit151.3070.8%14.3%
OPM24.52%17.97pp38.00pp
NPM21.45%13.95pp1.12pp
EPS8.4670.8%13.9%
View full financials

Informational and educational content only. Not investment advice.